Quality Intext Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 1094.37%
- Profit Growth 1344.34%
- Ebitda 795.69%
- Net Worth 2524.20%
- Total Assets 261.57%
About Quality Intext
Quality Intext Private Limited (QIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 March 2000 and has a history of 24 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Santosh Sharma and Shankardayal Sharma serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74994MH2000PTC124715
-
Company No.
124715
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Mar 2000
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Quality Intext?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Sharma
|
Director | 20-Jul-2011 | Current |
|
Shankardayal Sharma
|
Whole-Time Director | 01-Mar-2012 | Current |
Financial Performance of Quality Intext.
Quality Intext Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1094.37% increase. The company also saw a substantial improvement in profitability, with a 1344.34% increase in profit. The company's net worth Soared by an impressive increase of 2524.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quality Intext?
In 2021, Quality Intext had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Quality Nexgen Pharmaceuticals Private LimitedSantosh Sharma and Shankardayal Sharma are mutual person
Charges (Loans)
₹0
₹4.00 M
Charges Breakdown by Lending Institutions
- Central Bank Of India : 0.20 Cr
- Nkgsb Co-Op. Bank Ltd. : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2010 | Nkgsb Co-Op. Bank Ltd. | ₹2.00 M | Satisfied |
| 29 Feb 2008 | Central Bank Of India | ₹2.00 M | Satisfied |
How Many Employees Work at Quality Intext?
Unlock and access historical data on people associated with Quality Intext, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quality Intext, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quality Intext's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
